The Efficacy and Safety of Ta1 for Sepsis

NCT02867267 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1106

Enrollment

OTHER

Sponsor class

Conditions

Sepsis

Interventions

DRUG: Thymosin alpha 1
OTHER: Placebo

Sponsor

Sun Yat-sen University

Collaborators

[object Object]